Thousands of patients rely on Medtronic defibrillators to provide a life-saving shock to the heart when it stops. Unfortunately, these cardiac defibrillators have been subject to numerous recalls because they have been found to be unsafe. Patients with defective Medtronic defibrillators implanted can suffer serious complications and even death from these devices malfunctioning. Medtronic has had some 48 models of its defibrillators identified as “high risk.” Their defect might result in “arcing” during charging, which would result in the devices later failing when used during cardiac arrest.
FDA Announces Recall
In January 2018, the U.S. Food and Drug Administration (FDA) announced a nationwide recall of certain Medtronic defibrillators after discovering a defect that delivered unnecessary shocks and/or failed to deliver life-saving shocks when needed. Shocks delivered unnecessarily are incredibly painful and can cause additional complications for patients. These unnecessary shocks combined with other defects also deplete the device’s battery much more quickly than anticipated. Medtronic estimated nearly 8% of defibrillators would fail within the first two high-voltage charges, and up to 23% would fail if the device delivered the maximum number of shocks available in the lifetime of the battery. Just several months after the first recall, there was a second recall of Medtronic defibrillators that extended the recall to hundreds more devices.
What models are defective?
Implantable cardioverter-defibrillator models:
- Marquis VR 7230
- Marquis DR 7274
- Maximo VR 7232
- Maximo DR 7278
Cardiac resynchronization therapy defibrillators:
- InSync I Marquis
- InSync II Marquis
- InSync III Marquis
- InSync III Protect 7277
- InSync III Protect 7289
Medtronic Put Patients At Risk
Any company that manufactures and sells medical devices has a responsibility to make sure they are safe for use. This includes adequately testing all products before releasing them to market and providing warnings for patients of all risks and dangers associated with their products. Medtronic produced defective cardiac defibrillators and failed to warn consumers of their dangers.
In fact, this is not the first time Medtronic had to recall defective defibrillators. In 2010, the company agreed to pay $268 million to thousands of patients who were injured by a previous version of the company’s defibrillators. Patients affected by the defective defibrillators had to undergo additional surgeries to remove the devices and replace them with safer defibrillators. Not only did these victims suffer physically, they are also facing mounting medical bills and other financial hardships due to the damages caused by the defective device.
Patients Have A Right To Seek Compensation
Medtronic has no right to put patients’ lives at risk. If you or someone you love has had a defective Medtronic defibrillator removed, contact Dax F. Garza, P.C. today for a free consultation to discuss your case. We can help you understand your legal options and help you pursue compensation for your injuries.